Microbiological monitoring in patients with advanced ovarian cancer before and after cytoreductive surgery – a preliminary report
References
- 1. Gersetein CG, Damhuis RAM, de Vries M, Reedijk A, Burger CW, Kooi GS. Causes of postoperative mortality after surgery for ovarian cancer. Eur J Cancer. 2009;45:2799-803.
- 2. Chi DS, Eisenhauer EL, Zivanovic O, SonodaY, Abu-Rustum NR, Levine DA, et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol. 2009;114:26-31.
- 3. Capone A, Valle M, Proietti F, Federici O, Garofalo A, Petrosillo N. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis. J Surg Oncol. 2007;96:507-13.
10.1002/jso.20837 - 4. Dazza M, Schwarz L, Coget J, Frebourg N, Wood G, Huet E, et al. Does intraoperative systematic bacterial sampling during complete cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) inf luence postoperative treatment? A new predictive factor for postoperative abdominal infectious complications. World J Surg. 2016;40:3035-43.
10.1007/s00268-016-3635-6 - 5. Matsuo K, Prather CP, Ahn EH, Eno ML, Tierney KE, Yessaian AA, et al. Significance of perioperative infection in survival of patients with ovarian cancer. Int J Gynecol Cancer. 2012;22:245-53.
10.1097/IGC.0b013e31823bd6db - 6. Wołkowicz T, Januszkiewicz A, Szych J. Mikrobiom przewodu pokarmowego i jego dysbiozy jako istotny czynnik wpływający na kondycję zdrowotną organizmu człowieka. Med Dośw Mikrobiol. 2014;66:223-35.
- 7. Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human instestinal microbiota. Microbiology. 2010;156:3216-23.
- 8. Esposito S, Capuano A, Noviello S, Mazzeo F, Ianniello F, Filippelli A. Modification of patients’ endogenous bacterial flora during hospitalization in a large teaching hospital in Naples. J Chemother. 2003;15:568-73.
- 9. Siegel JD, Rhinehart E, Jackson M, Chiarello L. The Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;3:165-93.
www.cdc.gov/infectioncontrol/guidelines/mdro , last update: February, 15, 2017. - 10. Valle M, Federici O, Carboni F, Toma L, Gallo MT, Prignano G, et al. Postoperative infections after cytoreductive surgery and HIPEC for peritoneal carcinomatosis: Proposal and results from a prospective protocol study of prevention, surveillance and treatment. EJSO. 2014;40:950-6.
- 11. Harris AD, Nemoy L, Johnson JA, Martin-Carnahan A, Smith DL, Standiford H, et al. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epdemiol. 2004;25:105-8.
- 12. Ostrowsky BE, Venkataraman L, D’Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med. 1999;159:1467-72.
- 13. Warren DK, Nitin A, Hill C, Fraser VJ, Kollef MH. Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol. 2004;25: 99-104.
- 14. Tran CW, McGree ME, Weaver AL, Martin JR, Lemens MA, Cliby WA, et al. Surgical site infection after primary surgery for epithelial ovarian cancer: predictors and impact on survival. Gynecol Oncol. 2015;136:278-84.
- 15. Rafii A, Stoeckle E, Jean-Laurent M, Ferron G, Morice P, Houvenaeghel G, et al. Multi-center evaluation of post-operative morbidity and mortality after optimal cytroreductive surgery for advanced ovarian caner. Plose One.
10.1371/journal.pone.0039415">http://dx.doi.org/10.1371/journal.pone.0039415 , 2012 (accessed 23.07.2012).10.1371/journal.pone.0039415,2012(accessed23.07.2012) - 16. Sugarbaker PH. Peritonectomy procedures. Ann. Surg. 1995;221:29-42.
- 17. Sugarbaker PH, Alderman R, Edwards G, Marquardt CE, Gushchin V, Esquivel J, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol. 2006;13:635-44.
10.1245/ASO.2006.03.079 - 18. Capitano B, Nicolau DP. Evolving epidemiology and costs of resistance to antimicrobial agents in long-term care facilities. J Am Med Dir Assoc. 2003;4(3 Suppl):S90-9.
- 19. Alevizakos M, Gaitanidis A, Nasioudis D, Tori K, Flokas ME, Mylonakis E. Colonization with vancomycin-resistant enterococci and risk for bloodstream infection among patients with malignancy: a systemic review and meta-analysis. Open Forum Infect Dis.2017;4 (1):ofw246, Published online 2016 Dec. 7.
https://doi.org/10.1093/ofid/ofw246">https://doi.org/10.1093/ofid/ofw246 .10.1093/ofid/ofw246 - 20. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant enterococcus among patients with cancer. Am J Infect Control. 2006;34:534-6.
10.1016/j.ajic.2006.04.205 - 21. Tacconelli E. New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. Clin Microbiol Infect. 2006;12:102-9.
- 22. Kuehnert MJ, Jernigan JA, Pullen AL, Rimland D, Jarvis WR. Association between mucositis severity and vancomycin-resistant entrococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol. 1999;20: 660-3.
- 23. Zaas AK, Song X, Tucker P, Perl TM. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis. 2002;35:1139-46.
- 24. Almyroudis NG, Osawa R, Samonis G, Wetzler, Wang ES, McCarthy PL, et al. Discontinuation of systematic surveillance and contact precautions for vancomycin-resistant Enterococcus (VRE) and its impact on the incidence of VRE faecium bacteremia in patients with hematologic malignancies. Infect Control Hosp Epidemiol. 2016;37:398-403.
- 25. De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, et al. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systemic review and meta-analysis. J Antimicrob Chemother. 2014;69:1185-92.
- 26. Farr BM. Hospital wards spreading vancomycin-resistant enterococci to intensive care units: returning coals to Newcastle. Crit Care Med, 1998;26:1942-3.
10.1097/00003246-199812000-00008 - 27. Weinstein JW, Roe M, Towns M, Sanders L, Thorpe JJ, Corey GR, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol. 1996;17:36-41.
- 28. Kang ChI, Wi YM, Lee MY, Ko KS, Chung DR, Peck KR, et al. Epidemiology and risk factors of community onset infections caused by extended-spectrum ß-lactamase-producing Escherichia coli strains. J Clin Microbiol. 2012;50:312-7.
10.1128/JCM.06002-11 - 29. Rooney PJ, O’Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P. Nursing homes as a reservoir of extended-spectrum beta-lactamse (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother.2009;64: 635-41.
- 30. Freeman JT, Gormack S, De Almeida MN, Roberts SA. Natural history of rectal colonization with extended–spectrum betalactamase producing Enterobacteriaceae: a retrospective review with up to 6 years of follow-up. Healthcare Infection. 2013;18:152-5.
https://doi.org/10.1071/HI13013">https://doi.org/10.1071/HI13013 .10.1071/HI13013 - 31. Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol. 2004;25:838-41.
- 32. Zahar JR, Lortholary O, Martin C, Potel G, Plesiat P, Nordmann P. Addresssing the challenge of extended-spectrum beta-lactamases. Curr Opin Invest Drugs. 2009;10:172-80.
- 33. Demiraslan H, Cevahir F, Berk E, Metan G, Cetin M, Alp E. Is surveillance for colonization of carbapenem-resistant gram-negative bacteria important in adult bone marrow transplantation units? Am J Infect Control. 2017;45:735-9.
10.1016/j.ajic.2017.01.006 - 34. Zimmerman FS., Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41:190-4.
10.1016/j.ajic.2012.09.020 - 35. Zalecenia dotyczące postępowania w przypadku identyfikacji w zakładach opieki zdrowotnej szczepów bakterii Enterobacteriaceae wytwarzających karbapenemazy typu KPC.
http://www.antybiotyki.edu.pl/pdf/KPC-20100305 .
Language: English
Page range: 198 - 202
Submitted on: Sep 26, 2017
Accepted on: Dec 29, 2017
Published on: Mar 9, 2018
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2018 Maria Szymankiewicz, Krzysztof Koper, Konrad Dziobek, Zbigniew Kojs, Lukasz Wicherek, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.